Familial isolated growth hormone deficiency (IGHD) has been associated
with complete deletions of the hGH-N gene encoding the pituitary grow
th hormone (GH) in a large number of cases. However, there is still no
alternative empirical explanation for the remaining familial or non-f
amilial IGHD cases. We studied a large kindred including five IGHD-aff
ected first cousins to determine possible IGHD inheritance and whether
the hGH-N gene was the cause of IGHD in this pedigree. Sex-linked and
autosomal recessive transmission of IGHD in this kindred was rejected
. Autosomal dominant inheritance was the most probable explanation acc
ording to a model of one locus with two alleles, one being dominant fo
r IGHD, under genetic modifiers or epistasis. Southern blotting analys
is (BamHI and HindIII digestions) was used to determine whether the hG
H-N gene was present in the patients and their family members. Because
we found that the hGH-N gene was present, five restriction fragment l
ength polymorphisms (RFLPs; HincII, MspI-A and B, and BglII-A and B) l
inked to the hGH-N gene were used to try, to identify the possible RFL
P haplotypes in the pedigree that could be markers or associated with
the abnormal hGH-N alleles responsible for IGHD. From the haplotype an
alysis, it appeared that other genes not linked to the hGH-N gene clus
ter were the cause of the IGHD phenotype in this kindred. An alternati
ve conclusion could be that the hGH-N gene was responsible for IGHD in
this kindred, if a mutation (gene conversion) at the MspI-B site or a
reciprocal recombination event between the HincII and MspI-B sites oc
curred from generation P to F1 and a similar event took place from gen
eration F1 to F2. The non-significant GH responses of patients to the
growth releasing factor test confirmed that the hGH-N gene structural
product or some step in its regulation was responsible for causing IGH
D in this kindred. We suggest that genetic micromutations in the hGH-N
gene are present and are responsible for IGHD. We developed a method
using the polymerase chain reaction to amplify a 790-bp fragment of th
e hGH-N gene. The fragment spanned from the second part of the dyad sy
mmetry region in the non-transcribed 5' end of the hGH-N gene to 9 bp
before the alternative splice-acceptor site in exon 3. The expected fr
agment was verified by its digestion with seven diagnostic resctrictio
n endonucleases (BamHI, FspI, PstI, NdeI, BssHII, BglII and HincII). T
he results showed no deletions or insertions greater than 35 bp in the
hGH-N amplified fragment from the DNAs of the IGHD patients and their
family members.